Navigating the ERK1/2 MAPK Cascade

被引:32
作者
Martin-Vega, Ana [1 ]
Cobb, Melanie H. [1 ,2 ]
机构
[1] UT Southwestern Med Ctr, Dept Pharmacol, 6001 Forest Pk Rd, Dallas, TX 75390 USA
[2] UT Southwestern Med Ctr, Simmons Comprehens Canc Ctr, 6001 Forest Pk Rd, Dallas, TX 75390 USA
关键词
ERK1/2; MAPKs; cancer; scaffold; therapies; inhibitors; ACTIVATED PROTEIN-KINASE; SIGNAL-REGULATED KINASE; EPIDERMAL-GROWTH-FACTOR; SELECTIVE MEK1/2 INHIBITOR; IQGAP1 INTEGRATES CA2+/CALMODULIN; NEGATIVE FEEDBACK-REGULATION; EFFECTOR DOMAIN PROTEIN; RASGAP-RELATED PROTEIN; EMBRYONIC STEM-CELLS; OF-FUNCTION MUTATION;
D O I
10.3390/biom13101555
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The RAS-ERK pathway is a fundamental signaling cascade crucial for many biological processes including proliferation, cell cycle control, growth, and survival; common across all cell types. Notably, ERK1/2 are implicated in specific processes in a context-dependent manner as in stem cells and pancreatic beta-cells. Alterations in the different components of this cascade result in dysregulation of the effector kinases ERK1/2 which communicate with hundreds of substrates. Aberrant activation of the pathway contributes to a range of disorders, including cancer. This review provides an overview of the structure, activation, regulation, and mutational frequency of the different tiers of the cascade; with a particular focus on ERK1/2. We highlight the importance of scaffold proteins that contribute to kinase localization and coordinate interaction dynamics of the kinases with substrates, activators, and inhibitors. Additionally, we explore innovative therapeutic approaches emphasizing promising avenues in this field.
引用
收藏
页数:48
相关论文
共 550 条
  • [1] Discovery of a Highly Potent and Selective MEK Inhibitor: GSK1120212 (JTP-74057 DMSO Solvate)
    Abe, Hiroyuki
    Kikuchi, Shinichi
    Hayakawa, Kazuhide
    Iida, Tetsuya
    Nagahashi, Noboru
    Maeda, Katsuya
    Sakamoto, Johei
    Matsumoto, Noriaki
    Miura, Tomoya
    Matsumura, Koji
    Seki, Noriyoshi
    Inaba, Takashi
    Kawasaki, Hisashi
    Yamaguchi, Takayuki
    Kakefuda, Reina
    Nanayama, Toyomichi
    Kurachi, Hironori
    Hori, Yoshikazu
    Yoshida, Takayuki
    Kakegawa, Junya
    Watanabe, Yoshihiro
    Gilmartin, Aidan G.
    Richter, Mark C.
    Moss, Katherine G.
    Laquerre, Sylvie G.
    [J]. ACS MEDICINAL CHEMISTRY LETTERS, 2011, 2 (04): : 320 - 324
  • [2] IQGAP1: Insights into the function of a molecular puppeteer
    Abel, Alex M.
    Schuldt, Kristina M.
    Rajasekaran, Kamalakannan
    Hwang, David
    Riese, Matthew J.
    Rao, Sridhar
    Thakar, Monica S.
    Malarkannan, Subramaniam
    [J]. MOLECULAR IMMUNOLOGY, 2015, 65 (02) : 336 - 349
  • [3] Functional cloning and characterization of a novel nonhomeodomain protein that inhibits the binding of PBX1-HOX complexes to DNA
    Abramovich, C
    Shen, WF
    Pineault, N
    Imren, S
    Montpetit, B
    Largman, C
    Humphries, RK
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (34) : 26172 - 26177
  • [4] Functional characterization of multiple domains involved in the subcellular localization of the hematopoietic Pbx interacting protein (HPIP)
    Abramovich, C
    Chavez, EA
    Lansdorp, PM
    Humphries, RK
    [J]. ONCOGENE, 2002, 21 (44) : 6766 - 6771
  • [5] Nuclear export of MAP kinase (ERK) involves a MAP kinase kinase (MEK)-dependent active transport mechanism
    Adachi, M
    Fukuda, M
    Nishida, E
    [J]. JOURNAL OF CELL BIOLOGY, 2000, 148 (05) : 849 - 856
  • [6] AGT Gene-Angiotensinogen, GeneCards The Human Gene Database database online
  • [7] ERK2 stimulates MYC transcription by anchoring CDK9 to the MYC promoter in a kinase activity-independent manner
    Agudo-Ibanez, Lorena
    Morante, Marta
    Garcia-Gutierrez, Lucia
    Quintanilla, Andrea
    Rodriguez, Javier
    Munoz, Alberto
    Leon, Javier
    Crespo, Piero
    [J]. SCIENCE SIGNALING, 2023, 16 (794)
  • [8] PORE-ing over ERK substrates
    Ahn, Natalie G.
    [J]. NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2009, 16 (10): : 1004 - 1005
  • [9] β-Arrestin2 Regulates Lysophosphatidic Acid-Induced Human Breast Tumor Cell Migration and Invasion via Rap1 and IQGAP1
    Alemayehu, Mistre
    Dragan, Magdalena
    Pape, Cynthia
    Siddiqui, Iram
    Sacks, David B.
    Di Guglielmo, Gianni M.
    Babwah, Andy V.
    Bhattacharya, Moshmi
    [J]. PLOS ONE, 2013, 8 (02):
  • [10] Inhibition of caspase-9 through phosphorylation at Thr 125 by ERK MAPK
    Allan, LA
    Morrice, N
    Brady, S
    Magee, G
    Pathak, S
    Clarke, PR
    [J]. NATURE CELL BIOLOGY, 2003, 5 (07) : 647 - U45